Building on its growing reputation as a leader in the use of breakthrough technology, UHealth – University of Miami Health System has become the first academic medical center in the world to use the new da Vinci® Xi™ Surgical System. The procedure, a prostatectomy, was performed by Dipen Parekh, M.D., professor and chairman of urology and Director of Robotic Surgery, at University of Miami Hospital, the flagship hospital of UHealth, and is one of the surgical options available to patients at the Sylvester Comprehensive Cancer Center.
“Offering our expertise in robotic-assisted surgeries is a clear benefit for our patients,” said Parekh, who is a member of the Sylvester Comprehensive Cancer Center and a leading specialist in robotic and conventional urologic oncology surgical procedures. “The da Vinci Xi technology allows us to provide state-of-the-art technological advancements to our patients facing complex surgical procedures, and propels the UHealth and Sylvester medical teams to pave the way in clinical care.”
A team of Miller School researchers has found a strong correlation between the type of aortic valve replacement procedure a patient undergoes and the development of post-operative atrial fibrillation. Their findings are reported in an article, “New-Onset Atrial Fibrillation After Aortic Valve Replacement,” that appears in the April 22 issue of the Journal of the American College of Cardiology.
The International Comprehensive Epilepsy Center at University of Miami Hospital has been designated as a Level 4 Epilepsy Center by the National Association of Epilepsy Centers. The designation is the highest level awarded by the association, which evaluates the quality of specialized epilepsy care in the United States.
Alan S. Livingstone, M.D., the Lucille and DeWitt Daughtry Professor and Chairman of Surgery, is usually addressed as “Dr. Livingstone,” sometimes as “Professor Livingstone.” Now there is a new option: “Your Excellency.” On March 27, Livingstone was inducted into Brazil’s National Academy of Medicine, one of the oldest and most exclusive medical academies in the world, and the title accompanies that honor.
A group of Miller School scientists has received a $1.6 million small business award from the National Institute of Neurological Disorders and Stroke, a unit of the National Institutes of Health, to support development and clinical trials of a novel anti-inflammatory antibody treatment for human spinal cord injury.
The Miller School’s Department of Neurology is one of three institutions selected to participate in a collaborative research program to develop groundbreaking new methods of preventing, diagnosing and treating stroke, the second-leading cause of death worldwide. Funding began this month, and the department will receive $2.4 million over four years.